Lamitrin 25mg Tablet manages:
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Lamotrigine/Anti-epileptic Medicine
- Epilepsy: Used with other medications to manage seizures.
- Bipolar I Disorder: Long-term management to prolong the time between mood episodes in adults.
Lamitrin 25 may cause excessive drowsiness when taken with alcohol.
Lamitrin 25 may be unsafe during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will consider the benefits and potential risks before prescribing it.
Lamitrin 25 is probably safe during breastfeeding. Limited human data suggest it does not pose a significant risk to the baby. Monitor the baby for rash, sleepiness, or poor sucking, and get periodic platelet count and liver function tests.
Lamitrin 25 may cause dizziness and double vision, affecting your ability to drive.
Lamitrin 25 should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor.
Lamitrin 25 should be used with caution in patients with liver disease. Dose adjustment may be necessary. Consult your doctor.
It acts by inhibiting sodium currents (which is out of control in epileptic patients) via suppression of the release of glutamate (an excitatory brain chemical).
Lamitrin 25 belongs to a group of medicines called anti-epileptics. It is used to treat two conditions, epilepsy and bipolar disorder.
1. Inhibition of Sodium Channels:
2. Application in Bipolar Disorder:
3. Binding Properties and Receptor Interaction:
4. Inhibition of Calcium Currents:
This diverse receptor interaction and channel inhibition contribute to lamotrigine's efficacy in treating epilepsy, bipolar disorder, and possibly some neuropathic pain states.
Oral Epilepsy:
- Initial Dose: 25 mg once daily for 2 weeks.
- Second Phase: 50 mg once daily for 2 weeks.
- Maintenance Dose: Increase by 50-100 mg every 1-2 weeks to a usual dose of 100-200 mg daily, as a single dose or in 2 divided doses. Some patients may require up to 500 mg daily.
Adjunct in Epilepsy: With Valproate:
- Initial Dose: 25 mg on alternate days for 2 weeks.
- Second Phase: 25 mg once daily for 2 weeks.
- Maintenance Dose: Increase by 25-50 mg every 1-2 weeks to a usual dose of 100-200 mg daily in 1-2 divided doses.
With Enzyme-Inducing Antiepileptics (excluding Valproate):
- Initial Dose: 50 mg once daily for 2 weeks.
- Second Phase: 50 mg twice daily for 2 weeks.
- Maintenance Dose: Increase by 100 mg every 1-2 weeks to a usual dose of 200-400 mg daily in 2 divided doses; some patients may require up to 700 mg daily.
With Oxcarbazepine (excluding enzyme-inducing or -inhibiting antiepileptics):
- Initial Dose: 25 mg once daily for 2 weeks.
- Second Phase: 50 mg once daily for 2 weeks.
- Maintenance Dose: Increase by 50-100 mg every 1-2 weeks to a usual dose of 100-200 mg daily in 1-2 divided doses; some patients may require up to 500 mg daily.
Bipolar Disorder: Monotherapy:
- Initial Dose: 25 mg once daily for 2 weeks.
- Second Phase: 50 mg once daily for 2 weeks.
- Maintenance Dose: Double the daily dose weekly to a usual dose of 200 mg daily. Maximum dose is 200 mg/day.
With Valproate:
- Initial Dose: 25 mg every other day for 2 weeks.
- Second Phase: 25 mg once daily for 2 weeks.
- Maintenance Dose: Double the daily dose weekly to a usual dose of 100 mg daily.
With Enzyme-Inducing Antiepileptics (excluding Valproate):
- Initial Dose: 50 mg once daily for 2 weeks.
- Second Phase: 100 mg daily in 2 divided doses for 2 weeks.
- Maintenance Dose: Increase by 100 mg weekly to a usual dose of 400 mg daily in 2 divided doses.
Hepatic Impairment:
- Moderate Impairment (Child-Pugh category B): Reduce dose by about 50%.
- Severe Impairment (Child-Pugh category C): Reduce dose by about 75%.
Oral Epilepsy (Children >12 years):
- Initial Dose: 25 mg once daily for 2 weeks.
- Second Phase: 50 mg once daily for 2 weeks.
- Maintenance Dose: Increase by 50-100 mg every 1-2 weeks to a usual dose of 100-200 mg daily, as a single dose or in 2 divided doses. Some patients may require up to 500 mg daily.
Adjunct in Epilepsy (Children): With Valproate:
- Initial Dose: 0.15 mg/kg once daily for 2 weeks.
- Second Phase: 0.3 mg/kg once daily for 2 weeks.
- Maintenance Dose: Increase by 0.3 mg/kg every 1-2 weeks to a usual dose of 1-5 mg/kg once daily or in 2 divided doses.
Lamitrin 25 is not recommended for children under 12 years for the treatment of epilepsy.
Renal Impairment:
1. Enhanced Metabolism:
2. Reduced Metabolism:
Hypersensitivity.
Pregnancy Category C. Lamotrigine is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from Lamotrigine, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
1. Hepatic or Renal Impairment:
2. Monitoring:
3. Driving and Operating Machinery:
4. Pregnancy and Lactation:
5. Serious Risks:
Keep out of reach of children, Store in a dry place, below 25°C temperature, and protected from light.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.